An Ii-Key-containing HPV16/18 E7 epitope peptide vaccine promotes dendritic cell activation and T-cell immunity in a murine HPV16 tumor model, with greater tumor control upon PD-1 blockade
International Immunopharmacology · 2027-01 · 192 · 117694
DOI: 10.1016/j.intimp.2026.117694 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2027-01. Verfasst von Zixuan Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Pharmaceutical Sciences, Fudan University, Shanghai 201203, China. Die Arbeit nennt 50 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, School of Pharmaceutical Sciences, Fudan University, Shanghai 201203, China.
- Beijing Youfeng Biological Technology Co., Ltd., Beijing 100176, China.
- Beijing Youfeng Biological Technology Co., Ltd., Beijing 100176, China; Department of Medicinal Chemistry, College of Pharmaceutical Sciences, Capital Medical University, Beijing 100069, China.
- Department of Medicinal Chemistry, College of Pharmaceutical Sciences, Capital Medical University, Beijing 100069, China; Beijing Key Laboratory of Intelligent Clinical Data and AI-Driven Innovative Drug Development, Be…
- Department of Obstetrics and Gynecology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, China.
- Beijing Youfeng Biological Technology Co., Ltd., Beijing 100176, China. Electronic address: wangshaobo@youfeng-bj.com.
Zitieren
APA
Li, Z., Shen, L., Wang, X., Ren, H., Cui, C., Tao, X., Yao, X., Wang, X., Wang, Y., Qiu, J., Lu, Y., Wang, S., Wang, F., & Zhang, X. (2027). An Ii-Key-containing HPV16/18 E7 epitope peptide vaccine promotes dendritic cell activation and T-cell immunity in a murine HPV16 tumor model, with greater tumor control upon PD-1 blockade. International Immunopharmacology, 192, 117694. https://doi.org/10.1016/j.intimp.2026.117694
Vancouver
Li Z, Shen L, Wang X, Ren H, Cui C, Tao X, et al. An Ii-Key-containing HPV16/18 E7 epitope peptide vaccine promotes dendritic cell activation and T-cell immunity in a murine HPV16 tumor model, with greater tumor control upon PD-1 blockade. International Immunopharmacology. 2027;192:117694. doi:10.1016/j.intimp.2026.117694
BibTeX
@article{Li2027,
author = {Li, Zixuan and Shen, Liangliang and Wang, Xiaoning and Ren, Hu and Cui, Chun and Tao, Xiaoqian and Yao, Xiaohui and Wang, Xiaoyan and Wang, Yuji and Qiu, Jin and Lu, Yu and Wang, Shaobo and Wang, Feng and Zhang, Xuemei},
title = {An Ii-Key-containing HPV16/18 E7 epitope peptide vaccine promotes dendritic cell activation and T-cell immunity in a murine HPV16 tumor model, with greater tumor control upon PD-1 blockade},
journal = {International Immunopharmacology},
year = {2027},
volume = {192},
pages = {117694},
doi = {10.1016/j.intimp.2026.117694}
}
EUVIMED